Itorol


Combined with:

Aspirin
Lasix
Sigmart

Indications and Reactions:

Role Indications Reactions
Secondary
Hypertension 18.2%
Anxiety 7.5%
Anticoagulant Therapy 7.3%
Prophylaxis 6.7%
Angina Pectoris 6.5%
Cardiovascular Event Prophylaxis 6.3%
Coronary Artery Dilatation 6.3%
Drug Use For Unknown Indication 6.3%
Lipids Increased 5.5%
Antiplatelet Therapy 4.0%
Myocardial Infarction 3.8%
Product Used For Unknown Indication 3.8%
Cardiac Failure 3.6%
Constipation 2.9%
Gastritis 2.9%
Ill-defined Disorder 2.1%
Hyperlipidaemia 1.9%
Platelet Aggregation Inhibition 1.7%
Lipids Decreased 1.5%
Parkinson's Disease 1.3%
Hepatitis Acute 49.3%
Liver Disorder 13.0%
Pancytopenia 8.7%
Condition Aggravated 4.3%
Aspartate Aminotransferase Increased 2.9%
Death 2.9%
Drug Eruption 2.9%
Myocardial Infarction 2.9%
Road Traffic Accident 2.9%
Ammonia Increased 1.4%
Cardiac Failure 1.4%
Eczema 1.4%
Feeling Abnormal 1.4%
Pruritus 1.4%
Renal Impairment 1.4%
Urinary Tract Inflammation 1.4%
Concomitant
Angina Pectoris 17.4%
Hypertension 16.0%
Drug Use For Unknown Indication 9.0%
Prophylaxis 7.6%
Diabetes Mellitus 6.5%
Product Used For Unknown Indication 4.4%
Cardiac Failure 4.2%
Myocardial Infarction 3.9%
Hyperlipidaemia 3.7%
Rheumatoid Arthritis 3.6%
Cardiac Failure Chronic 3.2%
Insomnia 3.1%
Gastritis 2.8%
Constipation 2.6%
Hyperuricaemia 2.4%
Thrombosis Prophylaxis 2.3%
Type 2 Diabetes Mellitus 2.0%
Atrial Fibrillation 2.0%
Gastric Ulcer 1.8%
Asthma 1.6%
Hypoglycaemia 10.0%
Interstitial Lung Disease 8.8%
Renal Impairment 8.8%
Rhabdomyolysis 7.5%
Cardiac Failure 6.7%
Platelet Count Decreased 5.4%
Respiratory Failure 5.0%
Pneumonia 4.6%
Vomiting 4.6%
Sepsis 4.2%
Prostate Cancer 3.8%
Pyrexia 3.8%
Renal Failure 3.8%
Renal Failure Acute 3.8%
White Blood Cell Count Decreased 3.8%
Anaphylactic Shock 3.3%
Insomnia 3.3%
Liver Disorder 2.9%
Myocardial Infarction 2.9%
Rash 2.9%

Drug Data